Evidence map›Paper›PMID 38037115›Full record

ArticleGenome biology2023

ConDoR: tumor phylogeny inference with a copy-number constrained mutation loss model.

Palash Sashittal, Haochen Zhang, Christine A Iacobuzio-Donahue, Benjamin J Raphael

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Sc-TUSV-Ext: Single-Cell Clonal Lineage Inference from Single Nucleotide Variants, Copy Number Alterations, and Structural Variants.Journal of computational biology : a journal of computational molecular cell biology · 2025
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Mechanism of neurodegeneration mediated by clonal inflammatory microglia.bioRxiv : the preprint server for biology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Palash SashittalDepartment of Computer Science, Princeton University, NJ, USA.
Haochen ZhangGerstner Sloan Kettering Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, NY, USA.
Christine A Iacobuzio-DonahueHuman Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, NY, USA.
Benjamin J RaphaelDepartment of Computer Science, Princeton University, NJ, USA. braphael@princeton.edu.ORCID 0000-0003-1274-048X
Memorial Sloan Kettering Cancer Center · USPrinceton University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain MetastasisU2CCA233284 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI PE'ER, DANA · 2018 to 2022
$12.9M
Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and ActionabilityR35CA220508 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI IACOBUZIO-DONAHUE, CHRISTINE A · 2018 to 2024
$6.9M
Comprehensive and Robust Tools for Analysis of Tumor Heterogeneity and EvolutionU24CA248453 · NCI · PRINCETON UNIVERSITY · PI Benjamin Raphael · 2020 to 2026
$4.7M
Pathway and Network Integration of Cancer Genomics and Clinical DataU24CA211000 · NCI · PRINCETON UNIVERSITY · PI RAPHAEL, BENJAMIN, YEH, JEN JEN · 2016 to 2020
$1.7M
Pathway, Network and Spatiotemporal Integration of Cancer Genomics DataU24CA264027 · NCI · PRINCETON UNIVERSITY · PI RAPHAEL, BENJAMIN, YEH, JEN JEN · 2021 to 2025
$1.5M
NCI NIH HHS P30 CA008748NCI NIH HHS R35 CA220508NCI NIH HHS U24 CA211000NCI NIH HHS U24 CA248453NCI NIH HHS U24 CA264027NCI NIH HHS U2C CA233284NIH HHS R35CA220508NIH HHS U24CA211000NIH HHS U24CA264027NIH HHS U2CCA233284
6 · The paper itself

Abstract

A tumor contains a diverse collection of somatic mutations that reflect its past evolutionary history and that range in scale from single nucleotide variants (SNVs) to large-scale copy-number aberrations (CNAs). However, no current single-cell DNA sequencing (scDNA-seq) technology produces accurate measurements of both SNVs and CNAs, complicating the inference of tumor phylogenies. We introduce a new evolutionary model, the constrained k-Dollo model, that uses SNVs as phylogenetic markers but constrains losses of SNVs according to clusters of cells. We derive an algorithm, ConDoR, that infers phylogenies from targeted scDNA-seq data using this model. We demonstrate the advantages of ConDoR on simulated and real scDNA-seq data.

Indexed as

NeoplasmsAlgorithmsAnimalsBirdsDNA Copy Number VariationsHumansMutationPhylogenySequence Analysis, DNACancerDollo modelIntra-tumor heterogeneitySingle-cell DNA sequencingTumor phylogeny

Identifiers

PMID38037115
PMCPMC10688497
OpenAlexW4389199685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.